Evidence map›Paper›PMID 34050442›Full record

ArticleMikrochimica acta2021

Determination of VEGF

Jiangnan Li, Yang Liu, Changbao Wang, Qiaojuan Jia, Geyi Zhang, Xiaoyu Huang, Nan Zhou, Zhihong Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiangnan Li *Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052, People's Republic of China.
Yang Liu *Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052, People's Republic of China.
Changbao WangSchool of Materials and Chemical Engineering, Zhengzhou University of Light Industry, No. 136, Science Avenue, Zhengzhou, 450001, People's Republic of China.
Qiaojuan JiaSchool of Materials and Chemical Engineering, Zhengzhou University of Light Industry, No. 136, Science Avenue, Zhengzhou, 450001, People's Republic of China.
Geyi ZhangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052, People's Republic of China.
Xiaoyu HuangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052, People's Republic of China.
Nan ZhouDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052, People's Republic of China. fcczhoun@zzu.edu.cn.
Zhihong ZhangSchool of Materials and Chemical Engineering, Zhengzhou University of Light Industry, No. 136, Science Avenue, Zhengzhou, 450001, People's Republic of China. mainzhh@163.com.

Funding

Foundation for Distinguished Young Talents in Higher Education of Henan 202300410492National Natural Science Foundation of China 81601082National Natural Science Foundation of China 81771329National Natural Science Foundation of China 82071388Postdoctoral Research Foundation of China 2019M660175
6 · The paper itself

Abstract

A porous nanostructured covalent-organic framework (COF) has been prepared via condensation polymerization between the two building blocks of melem and hexaketocyclohexane octahydrate (represented as M-HO-COF). Basic characterizations revealed that the M-HO-COF network was composed of C=N and highly conjugated aromatic moieties, along with a high surface area, large pore size, remarkable electrochemical activity, and strong bioaffinity toward aptamer strands. Given that the vascular endothelial growth factor 165 (VEGF

Indexed as

Aptamers, NucleotideBiomarkers, TumorCell Line, TumorCyclohexanesElectrochemical TechniquesHeterocyclic Compounds, 3-RingHumansLimit of DetectionMetal-Organic FrameworksTriazinesVascular Endothelial Growth Factor AAptamers, NucleotideBiomarkers, TumorCyclohexanesHeterocyclic Compounds, 3-RingmelemMetal-Organic FrameworksTriazinesVascular Endothelial Growth Factor ACancer biomarkersCovalent-organic frameworkEarly diagnosisImpedimetric aptasensorMelem and hexaketocyclohexane octahydrate

Identifiers

PMID34050442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.